tirzepatide once weekly for the treatment of obesity journal club Updates Tirzepatide for maintenance of bodyweight
Description
What the clinical trial data actually shows Numbers matter here
00656-2/asset/ccb5d465-a316-405d-847e-f889e2a34a2c/main.assets/gr3_lrg.jpg)
Pancreatitis typically presents with severe epigastric pain radiating to the back and requires immediate medical evaluation and possible hospital admission

Avoiding high-fat, greasy, or heavily spiced foods during dose escalation helps significantly

Lying down with food still in your stomach (which will be the case on tirzepatide, since digestion is slowed) can trigger acid reflux and heartburn

The dual GIP/GLP-1 mechanism enhances insulin secretion in a glucose-dependent manner

Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for weight management) is an FDA-approved dual GIP and GLP-1 receptor agonist that effectively controls blood glucose and promotes weight loss
